Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s stock price traded down 3.4% during mid-day trading on Friday . The company traded as low as $131.5460 and last traded at $131.5460. 170 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 888 shares. The stock had previously closed at $136.21.
Merck KGaA Price Performance
The company has a 50 day moving average of $133.94 and a 200 day moving average of $131.83. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The stock has a market capitalization of $16.87 billion, a price-to-earnings ratio of 19.93 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Stories
- Five stocks we like better than Merck KGaA
- The 3 Best Fintech Stocks to Buy Now
- 2 Reasons to Load Up on Fiserv, 1 to Stay Away
- Growth Stocks: What They Are, What They Are Not
- 3 Stocks to Buy for the Evolution of AI Infrastructure
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- How Semtech’s Data Center Chips Are Powering the AI Boom
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
